Advanced Melanoma

Research conducted by Fillmore and colleagues highlights significant disparities in the presentation and prognosis of advanced melanoma within the veteran population compared to the general public. His work demonstrates that veterans are more likely to be diagnosed at regional or distant stages, contributing to lower overall survival rates. However, recent data indicate a notable improvement in two-year survival for veterans with stage IV disease.